Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:05:25 EST Mon 12 Jan 2026
Enter Symbol
or Name
USA
CA



Q:BIAF - BIOAFFINITY TECHNOLOGIES INC - https://bioaffinitytech.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BIAF - Q0.11.24·1.330.11.27-0.055-4.262.5732321.33  1.33  1.2646.53  1.110116:10:04Jan 0715 min RT 2¢

Recent Trades - Last 10 of 232
Time ETExPriceChangeVolume
16:10:04Q1.27-0.061
16:04:54Q1.27-0.061
16:00:01Q1.27-0.0634
16:00:01Q1.27-0.0693
16:00:01Q1.27-0.055224
16:00:01Q1.27-0.0677
16:00:01Q1.27-0.0680
16:00:01Q1.27-0.0618
16:00:01Q1.27-0.055300
16:00:01Q1.27-0.055115

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-07 08:00U:BIAFNews ReleasebioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
2025-12-03 08:00U:BIAFNews ReleasebioAffinity Technologies' Noninvasive CyPath(TM) Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
2025-11-14 08:00U:BIAFNews ReleasebioAffinity Technologies Reports Third Quarter 2025 Financial Results
2025-10-28 08:00U:BIAFNews ReleasebioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
2025-10-20 08:00U:BIAFNews ReleasebioAffinity Technologies Presents Research Supporting CyPath(TM) Lung Processing Methods at CHEST 2025
2025-10-16 08:00U:BIAFNews ReleasebioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
2025-10-15 08:00U:BIAFNews ReleasebioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
2025-10-09 14:00U:BIAFNews ReleaseWallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
2025-10-09 13:00U:BIAFNews ReleasebioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
2025-10-08 16:15U:BIAFNews ReleaseWallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
2025-10-08 15:45U:BIAFNews ReleasebioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
2025-10-07 08:00U:BIAFNews ReleasebioAffinity Technologies Reports Record Growth in CyPath(TM) Lung Test Volume for Third Quarter 2025
2025-09-30 12:30U:BIAFNews ReleaseWallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
2025-09-30 12:15U:BIAFNews ReleasebioAffinity Technologies Announces Closing of $4.8 Million Public Offering
2025-09-29 17:59U:BIAFNews ReleaseWallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m
2025-09-29 15:51U:BIAFNews ReleasebioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
2025-09-26 08:00U:BIAFNews ReleasebioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath(TM) Lung
2025-09-17 08:15U:BIAFNews ReleasebioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025
2025-09-09 08:00U:BIAFNews ReleaseCase Study: CyPath(TM) Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules
2025-09-03 08:00U:BIAFNews ReleaseU.S. Medicine Magazine Spotlights CyPath(TM) Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA